Genomines
PrivateLast Round
Series A
Sep 17, 2025
Total Funding Raised
$75.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genomines is a biotechnology company that provides plant-based mining services for sustainable metal extraction using genetically enhanced hyperaccumulator plants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomines Comparables
Compare Genomines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhytoMines | 84% | |
| Botanickel | 84% | |
| Econick | 82% | |
Genomines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 17, 2025 | ||||
| Grant | Jan 11, 2022 | ||||
| Grant | Jan 11, 2022 | ||||
| Seed | Oct 22, 2021 | ||||
| Seed | Aug 1, 2021 |
Key People
Founding team and executive leadership
Genomines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Engine Ventures | Series A |
| Forbion | Series A |
| Elemental Impact | Series A |
| DeepTech & Climate Fonds | Series A |
| RAISE Sherpas | Series A |
| Lowercarbon Capital | Series A, Seed |
| Engine Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 91% MoM, reaching 3.4K.
- Apr 1, 2026
Aidan D. promoted to Chief of Staff from internship.
Genomines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genomines's valuation, stock price, and market status.